{"DataElement":{"publicId":"4900695","version":"1","preferredName":"Primary Diagnosis Disease Group Classification Category","preferredDefinition":"A grouping of items based on the nature of disease group occurring first in signs and symptoms by scientific determination.","longName":"PrimDxDsCat","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4900693","version":"1","preferredName":"Primary Diagnosis Disease Group Classification","preferredDefinition":"information related to the nature of disease group occurring first in signs and symptoms by scientific determination.","longName":"Prim_Diag_Dise_Grou_Clas","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"3162677","version":"1","preferredName":"Primary Diagnosis","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C25251:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95BFC7C4-66AE-99D4-E040-BB89AD432F36","latestVersionIndicator":"Yes","beginDate":"2010-11-23","endDate":null,"createdBy":"WHITES","dateCreated":"2010-11-23","modifiedBy":"ONEDATA","dateModified":"2010-11-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4900691","version":"1","preferredName":"Disease or Disorder Group Classification","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Any number of entities (members) considered as a unit.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C2991:C43359:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AEEB012-02A4-8956-E050-BB89AD4324BF","latestVersionIndicator":"Yes","beginDate":"2015-07-15","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-15","modifiedBy":"ONEDATA","dateModified":"2015-07-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AEEB012-02B5-8956-E050-BB89AD4324BF","latestVersionIndicator":"Yes","beginDate":"2015-07-15","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4900694","version":"1","preferredName":"Primary Diagnosis Disease Category","preferredDefinition":"A grouping of items based on the nature of disease group occurring first in signs and symptoms by scientific determination.","longName":"PrimDxDsCat","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Renal","valueDescription":"Renal","ValueMeaning":{"publicId":"2567551","version":"1","preferredName":"Renal","longName":"2567551","preferredDefinition":"Of or pertaining to the kidney.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"CZECHS","dateModified":"2008-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B1BC96D-C9BF-979E-E050-BB89AD434C86","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Soft Tissue Sarcoma","valueDescription":"Soft Tissue Sarcoma","ValueMeaning":{"publicId":"3384698","version":"1","preferredName":"Soft Tissue Sarcoma","longName":"3384698","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A3DDB0-75C8-1600-E040-BB89AD432CFF","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B1BC96D-C9B5-979E-E050-BB89AD434C86","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Rare Tumors","valueDescription":"Rarely Tumor Mass","ValueMeaning":{"publicId":"4904671","version":"1","preferredName":"Rarely Tumor Mass","longName":"4904671","preferredDefinition":"Not often.: A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rarely","conceptCode":"C73116","definition":"Not often.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B1BC96D-C9CD-979E-E050-BB89AD434C86","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B1BC96D-C9E6-979E-E050-BB89AD434C86","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Osteosarcoma","valueDescription":"Osteosarcoma","ValueMeaning":{"publicId":"3179363","version":"1","preferredName":"Osteosarcoma","longName":"3179363","preferredDefinition":"A usually aggressive malignant bone-forming mesenchymal tumor, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteosarcoma","conceptCode":"C9145","definition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8659-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"REEVESD","dateModified":"2014-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B1BC96D-C9F0-979E-E050-BB89AD434C86","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Non-Hodgkin Lymphoma","valueDescription":"Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"2573076","version":"1","preferredName":"Non-Hodgkin Lymphoma","longName":"2573076","preferredDefinition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Hodgkin Lymphoma","conceptCode":"C3211","definition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA81-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-02-04","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0CFE-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Neuroblastoma","valueDescription":"Neuroblastoma","ValueMeaning":{"publicId":"4265259","version":"1","preferredName":"Neuroblastoma","longName":"4265259","preferredDefinition":"A neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroblastoma","conceptCode":"C3270","definition":"A malignant neuroblastic tumor characterized by the presence of neuroblastic cells, the absence of ganglion cells, and the absence of a prominent Schwannian stroma formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4CCE-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D08-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Myeloid Leukemia","valueDescription":"Myeloid Leukemia","ValueMeaning":{"publicId":"4903679","version":"1","preferredName":"Myeloid Leukemia","longName":"4903679","preferredDefinition":"A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are immature myeloid cells and myeloblasts, it is called acute myeloid leukemia. When the proliferating myeloid cells are neutrophils, it is called chronic myelogenous leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloid Leukemia","conceptCode":"C3172","definition":"A clonal proliferation of myeloid cells and their precursors in the bone marrow, peripheral blood, and spleen. When the proliferating cells are immature myeloid cells and myeloblasts, it is called acute myeloid leukemia. When the proliferating myeloid cells are neutrophils, it is called chronic myelogenous leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B153AB5-0D14-4322-E050-BB89AD433CC8","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D2D-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Mesoblastic Nephroma","valueDescription":"Congenital Mesoblastic Nephroma","ValueMeaning":{"publicId":"3251371","version":"1","preferredName":"Congenital Mesoblastic Nephroma","longName":"3251371","preferredDefinition":"A low grade childhood congenital malignant neoplasm arising from the kidney. It is characterized by the presence of fibroblastic cells. The majority of cases occur in the first year of life. Complete excision is usually associated with an excellent prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congenital Mesoblastic Nephroma","conceptCode":"C6569","definition":"A low grade childhood congenital malignant neoplasm arising from the kidney. It is characterized by the presence of fibroblastic cells. The majority of cases occur in the first year of life. Complete excision is usually associated with an excellent prognosis.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A758F49E-A264-73F4-E040-BB89AD430DFE","latestVersionIndicator":"Yes","beginDate":"2011-07-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D37-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Lymphoproliferative Disease","valueDescription":"Lymphoproliferative Disorder","ValueMeaning":{"publicId":"3235573","version":"1","preferredName":"Lymphoproliferative Disorder","longName":"3235573","preferredDefinition":"A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis). --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoproliferative Disorder","conceptCode":"C9308","definition":"A disorder characterized by proliferation of lymphocytes at various stages of differentiation. Lymphoproliferative disorders can be neoplastic (clonal, as in lymphomas and leukemias) or reactive (polyclonal, as in infectious mononucleosis).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A366F43E-37D9-9973-E040-BB89AD43108C","latestVersionIndicator":"Yes","beginDate":"2011-05-16","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D4B-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Lymphoblastic Leukemia","valueDescription":"Acute Lymphoblastic Leukemia","ValueMeaning":{"publicId":"3322383","version":"1","preferredName":"Acute Lymphoblastic Leukemia","longName":"3322383","preferredDefinition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Lymphoblastic Leukemia","conceptCode":"C3167","definition":"Leukemia with an acute onset, characterized by the presence of lymphoblasts in the bone marrow and the peripheral blood. It includes the acute B lymphoblastic leukemia and acute T lymphoblastic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB5D-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"ONEDATA","dateModified":"2011-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D5F-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Liver Tumor","valueDescription":"Liver Tumor Mass","ValueMeaning":{"publicId":"4903680","version":"1","preferredName":"Liver Tumor Mass","longName":"4903680","preferredDefinition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium.  It is the largest internal organ of the body, weighting up to 2 kg.  Metabolism and bile secretion are its main functions.  It is composed of cells which have the ability to regenerate.: A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B153AB5-0D6C-4322-E050-BB89AD433CC8","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D85-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Langerhans Cell Histiocytosis","valueDescription":"Langerhans Cell Histiocytosis","ValueMeaning":{"publicId":"2838588","version":"1","preferredName":"Langerhans Cell Histiocytosis","longName":"2838588","preferredDefinition":"A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination. Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease. The clinical course is generally related to the number of organs affected at presentation. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Langerhans Cell Histiocytosis","conceptCode":"C3107","definition":"A neoplastic proliferation of Langerhans cells which contain Birbeck granules by ultrastructural examination. Three major overlapping syndromes are recognized: eosinophilic granuloma, Letterer-Siwe disease, and Hand-Schuller-Christian disease. The clinical course is generally related to the number of organs affected at presentation. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A5F1C9-F6D7-B082-E040-BB89AD436154","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0D8F-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Hodgkin","valueDescription":"Hodgkin Lymphoma","ValueMeaning":{"publicId":"2573074","version":"1","preferredName":"Hodgkin Lymphoma","longName":"2573074","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of large tumor cells in an abundant admixture of nonneoplastic cells. There are two distinct subtypes: nodular lymphocyte predominant Hodgkin lymphoma and classical Hodgkin lymphoma. Hodgkin lymphoma involves primarily lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EA7F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-09","endDate":null,"createdBy":"KLINGERK","dateCreated":"2005-02-04","modifiedBy":"TAYLORT","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0DA4-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Germ Cell Tumor","valueDescription":"Germ Cell Tumor","ValueMeaning":{"publicId":"4265239","version":"1","preferredName":"Germ Cell Tumor","longName":"4265239","preferredDefinition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germ Cell Tumor","conceptCode":"C3708","definition":"A benign or malignant, gonadal or extragonadal neoplasm that originates from germ cells. Representative examples include teratoma, seminoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-7893-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"TAYLORT","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0DB8-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Ewing","valueDescription":"Ewing Sarcoma","ValueMeaning":{"publicId":"2593150","version":"1","preferredName":"Ewing Sarcoma","longName":"2593150","preferredDefinition":"A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ewing Sarcoma","conceptCode":"C4817","definition":"A small round cell tumor that lacks morphologic, immunohistochemical, and electron microscopic evidence of neuroectodermal differentiation. It represents one of the two ends of the spectrum called Ewing sarcoma/peripheral neuroectodermal tumor. It affects mostly males under age 20, and it can occur in soft tissue or bone. Pain and the presence of a mass are the most common clinical symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E8E-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0DCD-4322-E050-BB89AD433CC8","beginDate":"2015-07-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"CNS","valueDescription":"Central Nervous System","ValueMeaning":{"publicId":"4265337","version":"1","preferredName":"Central Nervous System","longName":"4265337","preferredDefinition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F694966F-2FEE-D003-E040-BB89AD430DBC","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"KUMMEROA","dateModified":"2022-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B153AB5-0DD7-4322-E050-BB89AD433CC8","beginDate":"2015-07-15","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-17","modifiedBy":"ONEDATA","dateModified":"2015-07-17","deletedIndicator":"No"},{"value":"Myeloproliferative Disease","valueDescription":"Mouse Myeloproliferative Disease","ValueMeaning":{"publicId":"4920292","version":"1","preferredName":"Mouse Myeloproliferative Disease","longName":"4920292","preferredDefinition":"A. Erythrocytosis, leukocytosis of myeloid cells, or thrombocytosis/circulating megakaryocytes AND B. Increased non-lymphoid hematopoietic cells in spleen and/or bone marrow; Comment: may be designated as having features of a named human MD/MPD or MPD","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mouse Myeloproliferative Disease","conceptCode":"C21903","definition":"A. Erythrocytosis, leukocytosis of myeloid cells, or thrombocytosis/circulating megakaryocytes AND B. Increased non-lymphoid hematopoietic cells in spleen and/or bone marrow; Comment: may be designated as having features of a named human MD/MPD or MPD","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B920451-75AE-12F3-E050-BB89AD432CF5","latestVersionIndicator":"Yes","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B920451-75C9-12F3-E050-BB89AD432CF5","beginDate":"2015-07-23","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-23","modifiedBy":"ONEDATA","dateModified":"2015-07-23","deletedIndicator":"No"},{"value":"Other blood disorder","valueDescription":"Other blood disorder","ValueMeaning":{"publicId":"5408212","version":"1","preferredName":"Other blood disorder","longName":"5408212","preferredDefinition":"Other blood disorder","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A23F272-93A5-A44F-E050-BB89AD430523","latestVersionIndicator":"Yes","beginDate":"2016-08-15","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3A23F272-93BE-A44F-E050-BB89AD430523","beginDate":"2016-08-15","endDate":null,"createdBy":"DAVISJ","dateCreated":"2016-08-15","modifiedBy":"ONEDATA","dateModified":"2016-08-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AF0C503-E8E3-3141-E050-BB89AD4337A0","latestVersionIndicator":"Yes","beginDate":"2015-07-15","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-15","modifiedBy":"TAYLORT","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Primary diagnosis disease gro","type":"Preferred Question Text","description":"Primary diagnosis disease group:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1AF0C503-E913-3141-E050-BB89AD4337A0","latestVersionIndicator":"Yes","beginDate":"2015-07-15","endDate":null,"createdBy":"WONGW","dateCreated":"2015-07-15","modifiedBy":"WONGW","dateModified":"2015-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}